Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudyAnthony J Barron, Alun D Hughes, Andrew Sharp, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Prediction of kidney-related outcomes in patients with type 2 diabetesMeg J Jardine, Jun Hata, Mark Woodward, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
Diabetes Care|June 25, 2015
Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303Graham S Hillis, Paul Welsh, John Chalmers, et al.
Journal of the American College of Cardiology|November 27, 2010
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trialG David Batty, Qiang Li, Sébastien Czernichow, et al.
Diabetes Care|October 4, 2013
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetesGraham S Hillis, Paul Welsh, John Chalmers, et al.
Journal of Hypertension|July 29, 2016
Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016Basden Onwubere, Antonio Coca, Albertino Damasceno, et al.
Diabetologia|September 3, 2016
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetesJoep van der Leeuw, Frank L J Visseren, Mark Woodward, et al.
Circulation|August 9, 2013
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trialJun Hata, Hisatomi Arima, Peter M Rothwell, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2009
Blood pressure variables and cardiovascular risk: new findings from ADVANCEAndre-Pascal Kengne, Sébastien Czernichow, Rachel Huxley, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudyAnthony J Barron, Alun D Hughes, Andrew Sharp, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Prediction of kidney-related outcomes in patients with type 2 diabetesMeg J Jardine, Jun Hata, Mark Woodward, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
Diabetes Care|June 25, 2015
Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303Graham S Hillis, Paul Welsh, John Chalmers, et al.
Journal of the American College of Cardiology|November 27, 2010
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trialG David Batty, Qiang Li, Sébastien Czernichow, et al.
Diabetes Care|October 4, 2013
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetesGraham S Hillis, Paul Welsh, John Chalmers, et al.
Journal of Hypertension|July 29, 2016
Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016Basden Onwubere, Antonio Coca, Albertino Damasceno, et al.
Diabetologia|September 3, 2016
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetesJoep van der Leeuw, Frank L J Visseren, Mark Woodward, et al.
Circulation|August 9, 2013
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trialJun Hata, Hisatomi Arima, Peter M Rothwell, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2009
Blood pressure variables and cardiovascular risk: new findings from ADVANCEAndre-Pascal Kengne, Sébastien Czernichow, Rachel Huxley, et al.
Pageof 18